
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Immunol.
Sec. T Cell Biology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1534530
This article is part of the Research Topic Advancing T Cell Biology: Novel Insights into Epitope Recognition and Immune Response Dynamics View all articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant, which can evade multiple neutralizing antibodies generated by prior infection or vaccination. Several knowledge gaps remain in terms of our understanding of the Omicron variant regarding CD8 T-cell immune reactivity. Here, we evaluated the characteristics of HLA-A2-restricted CD8 T-cell epitopes from the Omicron variant and performed a comprehensive analysis of epitope-specific CD8 T-cell responses to SARS-CoV-2 inactivated vaccines. Our data demonstrated that mutant epitopes in the SARS-CoV-2 variant Omicron caused escape from antigen presentation and CD8T-cell immune responses. We screened 2 epitopes causing CD8 T-cell responses to decrease after the Omicron variant. We identified an S protein epitope, 67A>V, which showed similar proportions of CD8 T specificity between the ancestral and mutant strains, indicating that this epitope is a conserved epitope with immunogenicity and may be used in a variety of vaccine development strategies. In addition, the third injection of the inactivated vaccine increased the number of epitope-specific CD8 T cells, highlighting the importance of boosters in increasing the number of cellular immune responses to the Omicron variant.
Keywords: SARS-CoV-2, omicron, Cellular Immune Response, CD8 T-cell epitope, Conserved epitope
Received: 26 Nov 2024; Accepted: 26 Feb 2025.
Copyright: © 2025 Xiao, Xiang, Peng, Gao, Li, Su, Gao, Shi, Mou, Yuan and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Chanchan Xiao, Jinan University, Guangzhou, China
Jun Yuan, Guangzhou Centers for Disease Control and Prevention, guangzhou, China
Guobing Chen, Jinan University, Guangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.